BlackRock Health Sciences Trust
BME
Get informed when a big investor buys or sells
+ FollowMarket Cap$514.38M
Close$
$1.30
96.7% downside
Current Fair Value
96.7% downsideOvervalued by 96.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $514.38 Million |
|---|---|
| Enterprise Value | $515.27 Million |
| Dividend Yield | $3.15 (7.90%) |
| Earnings per Share | $5.92 |
| Beta | 0.6 |
| Outstanding Shares | 12,924,103 |
Return
| Return on Equity | 17.67% |
|---|---|
| Return on Assets | 17.61% |
| Return on Invested Capital | 18.42% |
Valuation & Multiples
| P/E Ratio | 6.69 |
|---|---|
| PEG | -1.46 |
| Price to Sales | 9.97 |
| Price to Book Ratio | 0.93 |
| Enterprise Value to Revenue | 8.17 |
| Enterprise Value to EBIT | 4.91 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 20.32%▼ 1.22% |
|---|---|
| Total Invested | $101.76M▼ 10.88% |
| Investors Holding | 780% |
ESG Score
No data
About BlackRock Health Sciences Trust
CEO: John Perlowski BlackRock Health Sciences Trust’s (BME) (the 'Trust') investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment ob...